News

Deal Announcements

Augmenix Adds $3 Million Equity And Debt

Tuesday, January 4, 2011 5:59:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts  --  Medical device company Augmenix has received $3 million in new venture capital equity and debt according to an SEC regulatory filing.

Augmenix is developing in-situ formed, space filling hydrogels for radiation oncology and cancer surgery applications.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1